Advances in Laboratory Medicine (Jan 2024)

Clinical, biochemical, and molecular profiles of three Sri Lankan neonates with pyruvate carboxylase deficiency

  • Jasinge Eresha,
  • Fernando Mihika,
  • Indika Neluwa-Liyanage Ruwan,
  • Ratnayake Pyara Dilani,
  • Gamaathige Nalin,
  • Ratnaranjith Ratnanathan,
  • Schroeder Sabine,
  • Jones Patricia,
  • Volha Skrahina,
  • Jayasena Subhashinie,
  • Gunaratna Anusha Varuni,
  • Bandara Ekanayake Asitha Niroshana,
  • Rolfs Arndt

DOI
https://doi.org/10.1515/almed-2023-0102
Journal volume & issue
Vol. 5, no. 2
pp. 205 – 212

Abstract

Read online

Pyruvate carboxylase, a mitochondrial enzyme, catalyses the conversion of glycolytic end-product pyruvate to tricarboxylic acid cycle intermediate, oxaloacetate. Rare pyruvate carboxylase deficiency manifests in three clinical and biochemical phenotypes: neonatal onset type A, infantile onset type B and a benign C type. The objective of this case series is to expand the knowledge of overlapping clinical and biochemical phenotypes of pyruvate carboxylase deficiency.

Keywords